346 related articles for article (PubMed ID: 11356943)
21. Effects of the anticancer dehydrotarplatin on cytochrome P450 and antioxidant enzymes in male rat tissues.
Nannelli A; Messina A; Marini S; Trasciatti S; Longo V; Gervasi PG
Arch Toxicol; 2007 Jul; 81(7):479-87. PubMed ID: 17364183
[TBL] [Abstract][Full Text] [Related]
22. Altered enzyme activities of xenobiotic biotransformation in kidneys after subchronic administration of 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX) to rats.
Heiskanen K; Linström-Seppä P; Haataja L; Vaittinen SL; Vartiainen T; Komulainen H
Toxicology; 1995 Jun; 100(1-3):121-8. PubMed ID: 7624869
[TBL] [Abstract][Full Text] [Related]
23. [Dietary protein as a modulator of the activity of enzymes metabolizing xenobiotics. UDP glucuronosyltransferase and glutathione transferase].
Kravchenko LV; Tutel'ian VA
Vopr Pitan; 1990; (6):64-8. PubMed ID: 2127326
[TBL] [Abstract][Full Text] [Related]
24. Phase II-selective induction of hepatic drug-metabolizing enzymes by oltipraz -5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione-, 1,7-phenanthroline, and 2,2'-dipyridyl in rats is not accompanied by induction of intestinal enzymes.
Vargas M; Lamb JG; Franklin MR
Drug Metab Dispos; 1998 Feb; 26(2):91-7. PubMed ID: 9456293
[TBL] [Abstract][Full Text] [Related]
25. Effect of breed upon cytochromes P450 and phase II enzyme expression in cattle liver.
Giantin M; Carletti M; Capolongo F; Pegolo S; Lopparelli RM; Gusson F; Nebbia C; Cantiello M; Martin P; Pineau T; Dacasto M
Drug Metab Dispos; 2008 May; 36(5):885-93. PubMed ID: 18268077
[TBL] [Abstract][Full Text] [Related]
26. Oxidative metabolism of foreign compounds in rat small intestine: cellular localization and dependence on dietary iron.
Hoensch H; Woo CH; Raffin SB; Schmid R
Gastroenterology; 1976 Jun; 70(6):1063-70. PubMed ID: 817959
[TBL] [Abstract][Full Text] [Related]
27. Inhibition by oxonic acid of gastrointestinal toxicity of 5-fluorouracil without loss of its antitumor activity in rats.
Shirasaka T; Shimamoto Y; Fukushima M
Cancer Res; 1993 Sep; 53(17):4004-9. PubMed ID: 7689420
[TBL] [Abstract][Full Text] [Related]
28. Cytochrome P450-mediated metabolism in the human gut wall.
Thelen K; Dressman JB
J Pharm Pharmacol; 2009 May; 61(5):541-58. PubMed ID: 19405992
[TBL] [Abstract][Full Text] [Related]
29. Drug-metabolizing enzymes in respiratory nasal mucosa and liver of cynomolgus monkey.
Longo V; Mazzaccaro A; Ventura P; Gervasi PG
Xenobiotica; 1992 Apr; 22(4):427-31. PubMed ID: 1523863
[TBL] [Abstract][Full Text] [Related]
30. Characterization of xenobiotic metabolizing enzymes in bovine small intestinal mucosa.
Virkel G; Carletti M; Cantiello M; Della Donna L; Gardini G; Girolami F; Nebbia C
J Vet Pharmacol Ther; 2010 Jun; 33(3):295-303. PubMed ID: 20557447
[TBL] [Abstract][Full Text] [Related]
31. Phase 1 and phase 2 metabolic activities along the small intestine in adult male sheep.
Maté L; Virkel G; Lifschitz A; Sallovitz J; Ballent M; Lanusse C
J Vet Pharmacol Ther; 2010 Dec; 33(6):537-45. PubMed ID: 21062305
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor agent in animal model and in patients with impaired renal function.
Ikeda M; Furukawa H; Imamura H; Shimizu J; Ishida H; Masutani S; Tatsuta M; Kawasaki T; Satomi T
Cancer Chemother Pharmacol; 2002 Jul; 50(1):25-32. PubMed ID: 12111108
[TBL] [Abstract][Full Text] [Related]
33. Enhanced glucose absorption in the rat small intestine following repeated doses of 5-fluorouracil.
Tomimatsu T; Horie T
Chem Biol Interact; 2005 Aug; 155(3):129-39. PubMed ID: 15996645
[TBL] [Abstract][Full Text] [Related]
34. Dietary modulation of phase 1 and phase 2 activities with benzo(a)pyrene and related compounds in the intestine but not the liver of the channel catfish, Ictalurus punctatus.
James MO; Altman AH; Morris K; Kleinow KM; Tong Z
Drug Metab Dispos; 1997 Mar; 25(3):346-54. PubMed ID: 9172953
[TBL] [Abstract][Full Text] [Related]
35. The effect of short-term alloxan-induced diabetes on the activity of drug metabolizing enzymes.
Pachecka J; Kobylińska K; Suchocka Z; Kuczyńska J
Acta Pol Pharm; 1993; 50(6):435-9. PubMed ID: 8067257
[TBL] [Abstract][Full Text] [Related]
36. A possible mechanism of eighteen patient deaths caused by interactions of sorivudine, a new antiviral drug, with oral 5-fluorouracil prodrugs.
Okuda H; Ogura K; Kato A; Takubo H; Watabe T
J Pharmacol Exp Ther; 1998 Nov; 287(2):791-9. PubMed ID: 9808711
[TBL] [Abstract][Full Text] [Related]
37. Effects of Bu-Zhong-Yi-Qi-Tang on hepatic drug-metabolizing enzymes and plasma tolbutamide concentration in rats.
Yao HT; Chang YW; Uramaru N; Watanabe Y; Kitamura S; Kuo YH; Lii CK; Yeh TK
J Ethnopharmacol; 2012 Jun; 142(1):121-8. PubMed ID: 22564357
[TBL] [Abstract][Full Text] [Related]
38. Anticancer activity and toxicity of S-1, an oral combination of tegafur and two biochemical modulators, compared with continuous i.v. infusion of 5-fluorouracil.
Fukushima M; Shimamoto Y; Kato T; Uchida J; Yonekura R; Ohshimo H; Shirasaka T
Anticancer Drugs; 1998 Oct; 9(9):817-23. PubMed ID: 9840729
[TBL] [Abstract][Full Text] [Related]
39. The nifedipine-rifampin interaction. Evidence for induction of gut wall metabolism.
Holtbecker N; Fromm MF; Kroemer HK; Ohnhaus EE; Heidemann H
Drug Metab Dispos; 1996 Oct; 24(10):1121-3. PubMed ID: 8894514
[TBL] [Abstract][Full Text] [Related]
40. Zinc mediates normalization of hepatic drug metabolizing enzymes in chlorpyrifos-induced toxicity.
Goel A; Dani V; Dhawan DK
Toxicol Lett; 2007 Feb; 169(1):26-33. PubMed ID: 17194553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
